A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl®) after intramuscular and subcutaneous administration

By Mannaerts BMJL  

Human Reproduction, Vol. 13, Iss. 6, 1998-06 ,pp. : 1461-1464

Oxford University Press

Access to resources Recommend Favorite

Case report. Unexpected successful fertilization in vitro of oocytes retrieved 60 hours after human chorionic gonadotrophin injection

By Al-Mizyen ESS   Balet R   Lower AM   Wilson C   McClure AF   Al Shawaf T   Grudzinskas JG  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 1020-1021

Oxford University Press

Access to resources Recommend Favorite

A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles

By Kondapalli L.A.   Molinaro T.A.   Sammel M.D.   Dokras A.  

Human Reproduction, Vol. 27, Iss. 9, 2012-09 ,pp. : 2690-2697

Oxford University Press

Access to resources Recommend Favorite

Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.

By Valbuena D   Pellicer A   Guanes P P   Remohí J   Simón C  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2118-2122

Oxford University Press

Access to resources Recommend Favorite

Stimulation of cyclic AMP, 17beta-oestradiol and protein synthesis by human chorionic gonadotrophin in human endometrial cells.

By Chatterjee A   Jana N R   Bhattacharya S  

Human Reproduction, Vol. 12, Iss. 9, 1997-09 ,pp. : 1903-1908

Oxford University Press

Access to resources Recommend Favorite